D-Penicillamine Challenge Test Protocol for a 31-kg Child
Administer 500 mg of D-penicillamine orally at the start of a 24-hour urine collection and repeat the same 500 mg dose 12 hours later, regardless of the child's body weight. 1
Test Administration
- Dose: 500 mg D-penicillamine given orally at time 0 and again at 12 hours during the 24-hour urine collection period 1, 2, 3
- Timing: The standardized pediatric protocol uses a fixed dose of 500 mg twice (total 1000 mg over 24 hours), irrespective of body weight 1
- Administration requirements: D-penicillamine must be given on an empty stomach—at least one hour before meals or two hours after meals, and at least one hour apart from any other drug, food, or milk 4
Urine Collection Protocol
- Collection container: Use copper-free glassware or disposable containers to avoid copper contamination 1
- Baseline measurement: Collect a 24-hour baseline urinary copper excretion before administering penicillamine 1, 2
- Post-challenge measurement: Collect 24-hour urine during the penicillamine administration period 1, 2
- Quality control: Document exact urine volume and total creatinine excretion per 24 hours to ensure accurate determination 1
Interpretation Thresholds
- Diagnostic cutoff: Post-penicillamine urinary copper excretion >25 µmol/24 hours (approximately 1600 µg/24 hours) is considered diagnostic for Wilson's disease 1, 2, 3
- Test performance in symptomatic children: The test demonstrates 92% sensitivity (95% CI: 74-99%) and 93% specificity (95% CI: 83.8-98.2%) in children with active liver disease 2
- Critical limitation: The test has poor sensitivity (only 46%, 95% CI: 19.2-74.9%) in asymptomatic siblings and is unreliable for excluding Wilson's disease in this population 2
Important Clinical Caveats
The penicillamine challenge test has significant limitations and may not be necessary in many cases. Recent evidence suggests that using a lower threshold for baseline urinary copper excretion (>0.64 µmol/24 hours or 40 µg/24 hours) without D-penicillamine stimulation increases diagnostic sensitivity and may eliminate the need for the challenge test altogether 1, 5
- The test is most valuable when diagnosing Wilson's disease in children presenting with active liver disease 1, 2
- In one study, the penicillamine challenge test showed only 12.5% sensitivity compared to children with other liver diseases 1
- More recent data indicates that baseline urinary copper >40 µg/24 hours has 78.9% sensitivity and 87.9% specificity in asymptomatic children with mild liver disease, making the challenge test potentially unnecessary 5
Safety Monitoring
- Pyridoxine supplementation: Patients receiving penicillamine require daily pyridoxine (vitamin B6) supplementation because penicillamine increases pyridoxine requirements 4
- Hematologic monitoring: Although this is a single diagnostic test rather than chronic therapy, be aware that penicillamine can cause serious hematologic toxicity including aplastic anemia, agranulocytosis, and thrombocytopenia with chronic use 4, 6
Alternative Diagnostic Approach
Given the limitations of the penicillamine challenge test, consider prioritizing baseline 24-hour urinary copper excretion (threshold >40 µg/24 hours or 0.64 µmol/24 hours) combined with serum ceruloplasmin (<20 mg/dL), which together provide excellent diagnostic accuracy without the need for drug administration 1, 5